Skip to main navigation Skip to search Skip to main content

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

  • Philipp Heumann
  • , Miguel E. Aguado-Barrera
  • , Barbara Avuzzi
  • , David Azria
  • , Erik Briers
  • , Renée Bultijnck
  • , Ananya Choudhury
  • , Dirk De Ruysscher
  • , Marie Pierre Farcy-Jacquet
  • , Valérie Fonteyne
  • , Antonio Gómez Caamaño
  • , Irmgard Helmbold
  • , Kerstie Johnson
  • , Sarah L. Kerns
  • , Maarten Lambrecht
  • , Zoe Lingard
  • , Tiziana Rancati
  • , Barry S. Rosenstein
  • , Elena Sperk
  • , R. Paul Symonds
  • Christopher Talbot, Riccardo Valdagni, Ana Vega, Liv Veldeman, Tim Ward, Adam Webb, Catharine M. West, Jenny Chang-Claude, Petra Seibold*
*Corresponding author for this work
  • German Cancer Research Center
  • Instituto de Investigación Sanitaria de Santiago de Compostela
  • Fundación Pública Galega de Medicina Xenómica
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • Institut du Cancer Montpellier (ICM)
  • Patient Advocate
  • Ghent University Hospital
  • Ghent University
  • University of Manchester
  • Hôpital Carémeau
  • Complejo Hospitalario Universitario de Santiago
  • University of Leicester
  • Medical College of Wisconsin
  • University Hospitals Leuven
  • Icahn School of Medicine at Mount Sinai
  • Heidelberg University 
  • Fondazione IRCCS Istituto Nazionale dei Tumori
  • University of Milan
  • Centro de Investigación Biomédica en Red (CIBER)
  • UKNCRI CTRad Consumer
  • University Medical Center Hamburg-Eppendorf
  • MAASTricht Radiation Therapy and Oncology clinic (MAASTRO)

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
24 Downloads (Pure)

Abstract

Introduction: Previous studies showed that healthcare professionals and patients had only moderate to low agreement on their assessment of treatment-related symptoms. We aimed to determine the levels of agreement in a large cohort of prostate cancer patients. Methods: Analyses were made of data from 1,756 prostate cancer patients treated with external beam radiotherapy (RT) and/or brachytherapy in Europe and the USA and recruited into the prospective multicentre observational REQUITE study. Eleven pelvic symptoms at the end of RT were compared after translating patient-reported outcomes (PROs) into CTCAE-based healthcare professional ratings. Gwet's AC2 agreement coefficient and 95% confidence intervals were calculated for each symptom. To compare severity of grading between patients and healthcare professionals, percent agreement and deviations for each symptom were graphically depicted. Stratified and sensitivity analyses were conducted to identify potential influencing factors and to assess heterogeneity and robustness of results. Results: The agreement for the 11 pelvic symptoms varied from very good (AC2 > 0.8: haematuria, rectal bleeding, management of sphincter control) to poor agreement (AC2 ≤ 0.2: proctitis and urinary urgency). Fatigue had a negative impact on the agreement. Patients tended to grade symptoms more severely than healthcare professionals. Information on sexual dysfunction was missing more frequently in healthcare professional assessment than PROs. Conclusion: Agreement was better for observable than subjective symptoms, with patients usually grading symptoms more severely than healthcare professionals. Our findings emphasize that PROs should complement symptom assessment by healthcare professionals and be taken into consideration for clinical decision-making to incorporate the patient perspective.

Original languageEnglish
Article number109426
JournalRadiotherapy and Oncology
Volume178
DOIs
Publication statusPublished - Jan 2023
Externally publishedYes

Bibliographical note

Funding Information:
REQUITE was funded from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement #601826. The follow-up extension of the REQUITE patients is supported by ERA-NET ERA PerMed 2018 funding (BMBF, DS-CAT, ICSIII, FRRB, ANR) and BfS funding (#3619S42261).


Publisher Copyright:
© 2022 The Authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study'. Together they form a unique fingerprint.

Cite this